3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
6
Breast
5
Thoracic
3
Gynecologic
3
Sarcoma
2
Genitourinary
2
Dermatologic
2
Tumor-Agnostic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Head & Neck
1
Conditions
Lung Cancer - Malignant Pleural Mesothelioma
1
Interventions
Cisplatin
60
Carboplatin
55
Cyclophosphamide
47
Pemetrexed
45
Irinotecan
33
pembrolizumab
32
Paclitaxel
29
Etoposide
29
Gemcitabine
28
Nivolumab
24
Bevacizumab
24
Interviews as Topic
23
Vincristine
22
Capecitabine
22
Topotecan
20
Filgrastim
20
Early Intervention, Educational
20
fludarabine
19
Oxaliplatin
19
Docetaxel
19
Specimen Handling
18
Drug Therapy
18
Temozolomide
17
Sorafenib
17
Leucovorin
17
Everolimus
17
Educational Status
17
Radiotherapy
16
Methods
16
Fluorouracil
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
STA 9090
×
Other solid neoplasm
×
Clear all
NCT01590160
2019-11-13
MESO-02
University College, London
Phase 1/2
Completed
27 enrolled